Management of atrial fibrillation still suboptimal in Europe

Thursday, December 19, 2013 - 14:01 in Health & Medicine

Atrial fibrillation (AF) is the commonest cardiac rhythm disorder in Europe, and each of us have a one-in-four lifetime risk of developing it. Statistics show that oral anticoagulant use has increased, but new oral anticoagulant (NOAC) use is still low. Authors also concluded that compliance with treatment guidelines for patients with the lowest and higher stroke risk scores remains suboptimal.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net